Osteopontin Nanoparticles System for Drug Delivery
The present invention relates to nanoparticles comprising osteopontin and a polymer carrier, preferably a cationic carrier. Preferably, the cationic carrier is chitosan. Osteopontin and/or the cationic carrier may have bioactivity and/or the nanopar-ticle may comprise an additional component with bioactivity. Such additional bioactive component may e.g. be a siRNA. The nanoparticles of the invention may be used for treatment of bone diseases or inflammatory diseases.
Patents:CA 2,730,841
Inventor(s):
KJEMS JOERGEN [DK]; HOWARD KENNETH ALAN [DK]; BESENBACHER FLEMMING [DK]; ANDREASEN MORTEN [DK]
Type of Offer:
Sale
« More Nanotech Patents